AR092409A1 - Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona - Google Patents
Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanonaInfo
- Publication number
- AR092409A1 AR092409A1 ARP130103110A ARP130103110A AR092409A1 AR 092409 A1 AR092409 A1 AR 092409A1 AR P130103110 A ARP130103110 A AR P130103110A AR P130103110 A ARP130103110 A AR P130103110A AR 092409 A1 AR092409 A1 AR 092409A1
- Authority
- AR
- Argentina
- Prior art keywords
- approximately
- degrees
- ray diffraction
- diffraction pattern
- dihydroisoxazol
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 4
- 238000000113 differential scanning calorimetry Methods 0.000 abstract 2
- 238000001757 thermogravimetry curve Methods 0.000 abstract 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicación 1: Una forma cristalina A de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3H-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona, caracterizada porque exhibe al menos una de las propiedades siguientes: a) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83 y 20,07; b) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83 y 20,07, y que además comprende al menos un pico de difracción adicional expresado en grados 2q (± 0,2º) seleccionado del grupo que consiste en picos de aproximadamente 4,70, 9,39, 14,10, 15,70, 19,12, 20,97, 21;42, 22,03, 22,54, 23,62 y 28,42; c) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83 y 20,07, y que además comprende al menos un pico de difracción adicional expresado en grados 2q (± 0,2º) a aproximadamente 21,42, 22,54 y 28,42; d) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83, 20,07, 21,42, 22,54 y 28,42; e) un espectro de infrarrojos por transformada de Fourier en el intervalo de 1.800 a 600 cm⁻¹ sustancialmente como se muestra en la Figura 2; f) un termograma de calorimetría diferencial de barrido que tiene una única endotermia predominante a aproximadamente 145,53ºC a una velocidad de barrido de 10ºC por minuto, sustancialmente como se muestra en la Figura 3.1; y g) un termograma de calorimetría diferencial de barrido que tiene una única endotermia predominante en el intervalo de 144,01ºC a 146,92ºC a una velocidad de barrido de 10ºC por minuto, sustancialmente como se muestra en la Figura 3.2.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695410P | 2012-08-31 | 2012-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR092409A1 true AR092409A1 (es) | 2015-04-22 |
Family
ID=49115603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103110A AR092409A1 (es) | 2012-08-31 | 2013-08-30 | Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9200003B2 (es) |
| EP (1) | EP2890699B1 (es) |
| JP (1) | JP6109942B2 (es) |
| KR (1) | KR101736643B1 (es) |
| CN (1) | CN104812758B (es) |
| AR (1) | AR092409A1 (es) |
| AU (1) | AU2013308887B2 (es) |
| BR (1) | BR112015004135B8 (es) |
| CA (1) | CA2881467C (es) |
| CL (1) | CL2015000332A1 (es) |
| CY (1) | CY1120611T1 (es) |
| DK (1) | DK2890699T3 (es) |
| ES (1) | ES2671271T3 (es) |
| HR (1) | HRP20180861T1 (es) |
| HU (1) | HUE037667T2 (es) |
| LT (1) | LT2890699T (es) |
| MX (1) | MX351463B (es) |
| NO (1) | NO2931268T3 (es) |
| NZ (1) | NZ704175A (es) |
| PH (1) | PH12015500441A1 (es) |
| PL (1) | PL2890699T3 (es) |
| PT (1) | PT2890699T (es) |
| RS (1) | RS57284B1 (es) |
| RU (1) | RU2614978C2 (es) |
| SI (1) | SI2890699T1 (es) |
| TR (1) | TR201807735T4 (es) |
| WO (1) | WO2014036056A1 (es) |
| ZA (1) | ZA201500728B (es) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104602529B (zh) | 2012-09-07 | 2016-11-02 | 硕腾服务有限责任公司 | 螺环异噁唑啉杀寄生虫组合 |
| WO2014039489A1 (en) * | 2012-09-07 | 2014-03-13 | Zoetis Llc | Spirocyclic derivatives as antiparasitic agents |
| US20160081986A1 (en) * | 2013-05-20 | 2016-03-24 | Zoetis Services Llc | Long-acting spiro-isoxazoline antiparasitic compositions |
| US20170232024A1 (en) | 2014-08-04 | 2017-08-17 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| EP3204390B1 (en) | 2014-10-06 | 2019-06-05 | Basf Se | Substituted pyrimidinium compounds for combating animal pests |
| US20180368404A1 (en) | 2014-11-06 | 2018-12-27 | Basf Se | 3-pyridyl heterobicyclic compound for controlling invertebrate pests |
| BR112017021450B1 (pt) | 2015-04-07 | 2021-12-28 | Basf Agrochemical Products B.V. | Métodos de controle de pragas, método de melhoria da saúde vegetal e semente revestida |
| WO2016198613A1 (en) | 2015-06-11 | 2016-12-15 | Basf Se | N-(thio)acylimino compounds |
| WO2016198611A1 (en) | 2015-06-11 | 2016-12-15 | Basf Se | N-(thio)acylimino heterocyclic compounds |
| WO2017016883A1 (en) | 2015-07-24 | 2017-02-02 | Basf Se | Process for preparation of cyclopentene compounds |
| EA201890854A1 (ru) | 2015-10-02 | 2018-10-31 | Басф Се | Иминосоединения с 2-хлорпиримидин-5-ильным заместителем в качестве средств борьбы с вредителями |
| PL3383183T3 (pl) | 2015-11-30 | 2020-11-16 | Basf Se | Kompozycje zawierające cis-jasmon i bacillus amyloliquefaciens |
| BR112018068034A2 (pt) | 2016-03-09 | 2019-01-08 | Basf Se | compostos espiro da fórmula i, composição, composição agrícola para combater pragas animais, método de combate ou controle de pragas invertebradas, método de proteção de plantas, semente e uso dos compostos |
| EP3426042A1 (en) | 2016-03-11 | 2019-01-16 | Basf Se | Method for controlling pests of plants |
| CN108779121A (zh) | 2016-04-01 | 2018-11-09 | 巴斯夫欧洲公司 | 双环化合物 |
| WO2018082962A1 (en) * | 2016-11-02 | 2018-05-11 | Basf Se | Process for preparation of tetrahydrothiophene derivatives |
| MX2019007120A (es) | 2016-12-16 | 2019-09-16 | Basf Se | Compuestos plaguicidas. |
| WO2018162312A1 (en) | 2017-03-10 | 2018-09-13 | Basf Se | Spirocyclic derivatives |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
| US11160280B2 (en) | 2017-03-28 | 2021-11-02 | Basf Se | Pesticial compounds |
| MX2019011785A (es) | 2017-03-31 | 2019-11-18 | Basf Se | Proceso para preparar compuestos de 2,3-dihidrotiazolo[3,2-a]pirim idin-4-io quirales. |
| WO2018192793A1 (en) | 2017-04-20 | 2018-10-25 | Basf Se | Substituted rhodanine derivatives |
| KR20190141232A (ko) | 2017-04-26 | 2019-12-23 | 바스프 에스이 | 살충제로서의 치환된 숙신이미드 유도체 |
| UA125047C2 (uk) | 2017-05-10 | 2021-12-29 | Басф Се | Біциклічні пестицидні сполуки |
| WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
| WO2018229202A1 (en) | 2017-06-16 | 2018-12-20 | Basf Se | Mesoionic imidazolium compounds and derivatives for combating animal pests |
| BR112019025191B1 (pt) | 2017-06-19 | 2023-11-28 | Basf Se | Compostos de pirimidínio substituídos, composição, método para proteger culturas, semente revestida, uso dos compostos e uso de um composto |
| WO2018234488A1 (en) | 2017-06-23 | 2018-12-27 | Basf Se | Substituted cyclopropyl derivatives |
| WO2019042932A1 (en) | 2017-08-31 | 2019-03-07 | Basf Se | METHOD FOR CONTROLLING RICE PARASITES IN RICE |
| EP3453706A1 (en) | 2017-09-08 | 2019-03-13 | Basf Se | Pesticidal imidazole compounds |
| WO2019072906A1 (en) | 2017-10-13 | 2019-04-18 | Basf Se | IMIDAZOLIDINE PYRIMIDINIUM COMPOUNDS FOR CONTROL OF HARMFUL ANIMALS |
| WO2019099669A1 (en) * | 2017-11-16 | 2019-05-23 | Avista Pharma Solutions, Inc. | Single enantiomer antiparasitic compounds |
| AU2018385766B2 (en) | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| WO2019121143A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Substituted cyclopropyl derivatives |
| UA127604C2 (uk) | 2017-12-21 | 2023-11-01 | Басф Се | Пестицидні сполуки |
| WO2019145140A1 (en) | 2018-01-09 | 2019-08-01 | Basf Se | Silylethynyl hetaryl compounds as nitrification inhibitors |
| WO2019137995A1 (en) | 2018-01-11 | 2019-07-18 | Basf Se | Novel pyridazine compounds for controlling invertebrate pests |
| KR20200128052A (ko) | 2018-02-28 | 2020-11-11 | 바스프 에스이 | 질화작용 저해제로서의 알콕시피라졸의 용도 |
| KR102730587B1 (ko) | 2018-02-28 | 2024-11-14 | 바스프 에스이 | 질화작용 저해제로서의 n-관능화 알콕시 피라졸 화합물의 용도 |
| WO2019166558A1 (en) | 2018-02-28 | 2019-09-06 | Basf Se | Use of pyrazole propargyl ethers as nitrification inhibitors |
| WO2019175713A1 (en) | 2018-03-14 | 2019-09-19 | Basf Corporation | New catechol molecules and their use as inhibitors to p450 related metabolic pathways |
| WO2019175712A1 (en) | 2018-03-14 | 2019-09-19 | Basf Corporation | New uses for catechol molecules as inhibitors to glutathione s-transferase metabolic pathways |
| WO2019185413A1 (en) | 2018-03-27 | 2019-10-03 | Basf Se | Pesticidal substituted cyclopropyl derivatives |
| WO2019219529A1 (en) | 2018-05-15 | 2019-11-21 | Basf Se | Mixtures comprising benzpyrimoxan and oxazosulfyl and uses and methods of applying them |
| WO2019224092A1 (en) | 2018-05-22 | 2019-11-28 | Basf Se | Pesticidally active c15-derivatives of ginkgolides |
| WO2020002472A1 (en) | 2018-06-28 | 2020-01-02 | Basf Se | Use of alkynylthiophenes as nitrification inhibitors |
| HUE064943T2 (hu) | 2018-07-23 | 2024-04-28 | Basf Se | Szubsztituált tiazolidin vegyület alkalmazása nitrifikációs inhibitorként |
| US12122728B2 (en) | 2018-07-23 | 2024-10-22 | Basf Se | Use of substituted 2-thiazolines as nitrification inhibitors |
| EP3613736A1 (en) | 2018-08-22 | 2020-02-26 | Basf Se | Substituted glutarimide derivatives |
| EP3628156A1 (en) | 2018-09-28 | 2020-04-01 | Basf Se | Method for controlling pests of sugarcane, citrus, rapeseed, and potato plants |
| BR112021004526A2 (pt) | 2018-09-28 | 2021-06-08 | Basf Se | uso do composto, métodos de proteção de plantas, de controle ou combate a pragas invertebradas e de tratamento de sementes e semente |
| EP3628158A1 (en) | 2018-09-28 | 2020-04-01 | Basf Se | Pesticidal mixture comprising a mesoionic compound and a biopesticide |
| EP3628157A1 (en) | 2018-09-28 | 2020-04-01 | Basf Se | Method of controlling insecticide resistant insects and virus transmission to plants |
| EP3643705A1 (en) | 2018-10-24 | 2020-04-29 | Basf Se | Pesticidal compounds |
| EP3887357A1 (en) | 2018-11-28 | 2021-10-06 | Basf Se | Pesticidal compounds |
| WO2020126591A1 (en) | 2018-12-18 | 2020-06-25 | Basf Se | Substituted pyrimidinium compounds for combating animal pests |
| EP3696177A1 (en) | 2019-02-12 | 2020-08-19 | Basf Se | Heterocyclic compounds for the control of invertebrate pests |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| EP3769623A1 (en) | 2019-07-22 | 2021-01-27 | Basf Se | Mesoionic imidazolium compounds and derivatives for combating animal pests |
| WO2020239517A1 (en) | 2019-05-29 | 2020-12-03 | Basf Se | Mesoionic imidazolium compounds and derivatives for combating animal pests |
| EP3766879A1 (en) | 2019-07-19 | 2021-01-20 | Basf Se | Pesticidal pyrazole derivatives |
| WO2022061914A1 (zh) * | 2020-09-28 | 2022-03-31 | 台州臻挚生物科技有限公司 | 一种3,5-二卤三氟苯乙酮及其衍生物的制备方法 |
| EP4288398A1 (en) | 2021-02-02 | 2023-12-13 | Basf Se | Synergistic action of dcd and alkoxypyrazoles as nitrification inhibitors |
| CN117355504A (zh) | 2021-05-21 | 2024-01-05 | 巴斯夫欧洲公司 | 乙炔基吡啶化合物作为硝化抑制剂的用途 |
| AR125955A1 (es) | 2021-05-21 | 2023-08-30 | Basf Se | Uso de un compuesto de alcoxi pirazol n-funcionalizado como inhibidor de nitrificación |
| WO2022268810A1 (en) | 2021-06-21 | 2022-12-29 | Basf Se | Metal-organic frameworks with pyrazole-based building blocks |
| WO2022271933A1 (en) | 2021-06-23 | 2022-12-29 | Kimtron, Inc. | System and method for ultra-close proximity irradiation of rotating biomass |
| WO2023203066A1 (en) | 2022-04-21 | 2023-10-26 | Basf Se | Synergistic action as nitrification inhibitors of dcd oligomers with alkoxypyrazole and its oligomers |
| KR20250041029A (ko) | 2022-08-02 | 2025-03-25 | 바스프 에스이 | 피라졸로 살충 화합물 |
| CN117263825A (zh) * | 2023-11-23 | 2023-12-22 | 内蒙古百灵科技有限公司 | 一种双甲脒结晶的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1007310A2 (pt) * | 2009-01-22 | 2015-08-25 | Syngenta Participations Ag | Compostos inseticidas. |
| EP2539335B1 (en) * | 2010-02-25 | 2016-12-21 | Syngenta Participations AG | Process for the preparation of isoxazoline derivatives |
| BR112013002871B1 (pt) * | 2010-08-05 | 2018-11-21 | Zoetis Llc | derivados de isoxazolina, seu uso e composição farmacêutica ou veterinária |
| WO2012086462A1 (ja) * | 2010-12-20 | 2012-06-28 | 日本曹達株式会社 | イソオキサゾリン化合物および有害生物防除剤 |
| PL2683723T3 (pl) * | 2011-03-10 | 2017-07-31 | Zoetis Services Llc | Spirocykliczne pochodne izoksazoliny jako środki przeciwpasożytnicze |
-
2013
- 2013-08-28 RS RS20180636A patent/RS57284B1/sr unknown
- 2013-08-28 US US14/422,098 patent/US9200003B2/en active Active
- 2013-08-28 JP JP2015529970A patent/JP6109942B2/ja active Active
- 2013-08-28 HR HRP20180861TT patent/HRP20180861T1/hr unknown
- 2013-08-28 ES ES13756985.1T patent/ES2671271T3/es active Active
- 2013-08-28 CN CN201380044821.9A patent/CN104812758B/zh active Active
- 2013-08-28 HU HUE13756985A patent/HUE037667T2/hu unknown
- 2013-08-28 EP EP13756985.1A patent/EP2890699B1/en active Active
- 2013-08-28 RU RU2015107052A patent/RU2614978C2/ru active
- 2013-08-28 PT PT137569851T patent/PT2890699T/pt unknown
- 2013-08-28 AU AU2013308887A patent/AU2013308887B2/en active Active
- 2013-08-28 TR TR2018/07735T patent/TR201807735T4/tr unknown
- 2013-08-28 WO PCT/US2013/056945 patent/WO2014036056A1/en not_active Ceased
- 2013-08-28 LT LTEP13756985.1T patent/LT2890699T/lt unknown
- 2013-08-28 DK DK13756985.1T patent/DK2890699T3/en active
- 2013-08-28 NZ NZ704175A patent/NZ704175A/en unknown
- 2013-08-28 PL PL13756985T patent/PL2890699T3/pl unknown
- 2013-08-28 CA CA2881467A patent/CA2881467C/en active Active
- 2013-08-28 MX MX2015002679A patent/MX351463B/es active IP Right Grant
- 2013-08-28 BR BR112015004135A patent/BR112015004135B8/pt active IP Right Grant
- 2013-08-28 SI SI201331062T patent/SI2890699T1/en unknown
- 2013-08-28 KR KR1020157004953A patent/KR101736643B1/ko active Active
- 2013-08-30 AR ARP130103110A patent/AR092409A1/es unknown
- 2013-12-13 NO NO13863231A patent/NO2931268T3/no unknown
-
2015
- 2015-01-30 ZA ZA2015/00728A patent/ZA201500728B/en unknown
- 2015-02-11 CL CL2015000332A patent/CL2015000332A1/es unknown
- 2015-02-27 PH PH12015500441A patent/PH12015500441A1/en unknown
-
2018
- 2018-06-13 CY CY181100619T patent/CY1120611T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092409A1 (es) | Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona | |
| MX374729B (es) | Compuestos de heteroarilo o arilo biciclicos fusionados y su uso como inhibidores irak4. | |
| AR101403A1 (es) | (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi-2,8-dimetilo-1,4-dihidro-1,6-naftiridin-3-carboxamida, su purificación para su uso como principio activo farmacéutico, un procedimiento para su preparación y su empleo en el tratamiento de enfermedades cardiovasculares | |
| EA202192151A1 (ru) | Применение пиразолпиримидиновых производных для лечения нарушений, связанных с pi3k | |
| DOP2016000281A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer | |
| UY34480A (es) | Compuestos de 2-(fenilo sustituido)-ciclopentan-1,3-diona y derivados de los mismos, composiciones y métodos para controlar malezas. | |
| MX392230B (es) | Pirimidina-2-ilamino-1h-pirazoles como inhibidores de lrrk2 para el uso en el tratamiento de trastornos neurogenerativos. | |
| EA201790766A1 (ru) | Новые соединения метилпиперидина, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
| CR20140084A (es) | Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2 | |
| CL2015001377A1 (es) | Inhbibidores de bmi-1 primidinas sustituidas inversas | |
| TW201613872A (en) | IRAK4 inhibiting agents | |
| CL2016000466A1 (es) | Compuestos derivados de 2-amino pirimidina sustituida, inhibidores de bmi-1 composicion farmaceutica y uso en el tratamiento del cancer. | |
| EA201791305A1 (ru) | Конденсированные пиримидины для лечения вич | |
| CO2017001884A2 (es) | Polimorfos de selinexor | |
| DOP2016000308A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| AR106612A1 (es) | Sales, formas cristalinas y composiciones farmacéuticas de 4-[2-(4-amino-piperidin-1-il)-5-(3-fluoro-4-metoxi-fenil)-1-metil-6-oxo-1,6-dihidro-pirimidin-4-il]-2-fluorobenzonitrilo como inhibidor de demetilasa 1 específica de lisina | |
| NZ625684A (en) | Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines | |
| ECSP17010481A (es) | Novedosas pirimidinas 2,5-sustituidas | |
| MX389545B (es) | Compuestos terapeuticos y composiciones para el tratamiento de trastornos sociales y trastornos de uso de sustancias. | |
| CO2017001528A2 (es) | Compuestos novedosos de pirimidina sustituidos | |
| CL2016000496A1 (es) | Compuestos derivados de 1,2,4-triazolo[1,5-a]-piridina, inhibidores de una janus cinasa, tal como jak1; composiciones farmacológicas; útiles para el tratamiento de enfermedades inflamatorias. | |
| MD20170011A2 (ro) | Compuşi imidazopiridazinici | |
| EA201891050A1 (ru) | Соединения пирроло-, пиразоло-, имидазопиримидина и пиридина, которые ингибируют mnk1 и mnk2 | |
| CO2017001523A2 (es) | Novedosas pirimidinas 2,5-sustituidas | |
| CL2020001346A1 (es) | Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |